206 related articles for article (PubMed ID: 1725030)
1. Effects of ramipril on arterial hemodynamics.
Benetos A; Vasmant D; Thiéry P; Safar M
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S153-6. PubMed ID: 1725030
[TBL] [Abstract][Full Text] [Related]
2. Long lasting arterial effects of the ACE inhibitor ramipril.
Benetos A; Asmar R; Vasmant D; Thiéry P; Safar M
J Hum Hypertens; 1991 Oct; 5(5):363-8. PubMed ID: 1837563
[TBL] [Abstract][Full Text] [Related]
3. Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension.
Stumpe KO; Overlack A; Kolloch R; Schatz J; Witte PU; Pahnke K
Klin Wochenschr; 1986 Jun; 64(12):558-62. PubMed ID: 3016405
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
Mroczek WJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
[TBL] [Abstract][Full Text] [Related]
5. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.
Mahmud A; Feely J
J Hum Hypertens; 2000 Sep; 14(9):541-6. PubMed ID: 10980584
[TBL] [Abstract][Full Text] [Related]
6. Effect of converting enzyme inhibitors on hypertensive large arteries in humans.
Safar ME; Laurent SL; Bouthier JD; London GM; Mimran AR
J Hypertens Suppl; 1986 Dec; 4(5):S285-9. PubMed ID: 3033179
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.
London GM; Pannier B; Vicaut E; Guérin AP; Marchais SJ; Safar ME; Cuche JL
J Hypertens; 1996 Sep; 14(9):1139-46. PubMed ID: 8986916
[TBL] [Abstract][Full Text] [Related]
8. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
Lenz T; Distler A; Haller H; Meyer-Sabellek W; Wilp C; Tansey MJ; Eckert HG; Metzger H; Irmisch R; Philipp T
Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers.
Thuillez C; Richer C; Giudicelli JF
Am J Cardiol; 1987 Apr; 59(10):38D-44D. PubMed ID: 3034032
[TBL] [Abstract][Full Text] [Related]
10. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
Am J Cardiol; ; . PubMed ID: 3034041
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
